Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand

Pepple, Kathryn L.Wilson, LeslieVan Gelder, Russell N.Kovaleva, MarinaUbah, Obinna C.Steven, JohnBarelle, Caroline J.Porter, Andrew2019-09-202019-09-202019-09Pepple, K L, Wilson, L, Van Gelder, R N, Kovaleva, M, Ubah, O C, Steven, J, Barelle, C J & Porter, A 2019, 'Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand', Translational vision science & technology, vol. 8, no. 5, 11. https://doi.org/10.1167/tvst.8.5.112164-2591Bibtex: urn:303e8764f82bb0ce21126895764c94a5http://hdl.handle.net/2164/12970Acknowledgments Supported by an unrestricted departmental grant from Research to Prevent Blindness (New York, NY), NEI K08EY023998 (KLP), P30-EY001730 (RVG; Bethesda, MD), by a grant from Elasmogen Limited (RVG), and with support from the Mark J. Daily, MD Research Fund (RVG, KLP).131192034enguveitistreatmentTNF-alphaexperimental autoimmune uveitisLewis ratTreatmentUveitisExperimental autoimmune uveitisADALIMUMABAQUEOUS-HUMORNONINFECTIOUS UVEITISINDUCTIONBODY-WEIGHTINTRAVITREAL INFLIXIMABCORTICOSTEROIDSEXPRESSIONADVERSE EVENTSEPIDEMIOLOGYR Medicine (General)OphthalmologyBiomedical EngineeringR1Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory LigandJournal article10.1167/tvst.8.5.11http://www.scopus.com/inward/record.url?scp=85073466643&partnerID=8YFLogxK85